Sernova Corp. is a listed company. Its insiders report their share dealings to SEDI. Nothing new has been filed by managers of Sernova Corp. in twelve months, the latest record being from 13 September 2024.
Looking back to 2009, when coverage begins, insiders filed 18 purchases and 8 sales.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 77 declarations
Sernova Corp. is a Canadian company focused on developing technologies for the treatment of chronic diseases. It specializes in innovative solutions for cell therapy and regenerative medicine.